ACT NO. 164
Regulated drugs; precursor drugs of methamphetamine
This act places restrictions on the possession and sale of ephedrine, pseudoephedrine, and phenylpropanolamine, drugs which are used in the manufacture of methamphetamine. These drugs, sometimes called methamphetamine precursors, are present in many commonly used cold and allergy medications.
The act prohibits any person from possessing any of the precursors with the intent of use for the manufacture of methamphetamine or another controlled substance. The act provides that any product sold at retail which contains one of the precursor drugs must be maintained in a locked display case or behind the counter out of the public's reach, and prohibits a retail establishment from knowingly selling to a person any drug product containing more than 3.6 grams of the precursor drugs. Violations of the prohibition on possession of precursors with the intent to manufacture methamphetamine are criminal offenses, while violations of the retail restrictions on drug products containing methamphetamine precursors are civil offenses.
The act also requires the department of health to develop a publicity and education program to explain the need for change in public access to methamphetamine precursors.
Effective Date: September 30, 2006
The Vermont General Assembly
115 State Street